Serum has described the volunteer’s accusations as “malicious and ill-conceived” (Representative) New Delhi: A Chennai volunteer whose allegations of adverse effects during the Oxford vaccine trials led to a Rs 100 million lawsuit by the Serum Institute of India (SII), lost an American project and found it difficult to even …
Read More »
Union Health Minister Harsh Vardhan said on Monday that the central government plans to vaccinate between 25 and 30 million people against the new coronavirus by July-August next year. “In the first 3-4 months of next year, there is a possibility that we can provide vaccines to the people of …
Read More »
Prime Minister Narendra Modi will fly to Hyderabad, Ahmedabad and Pune on Saturday to take stock of the development of the COVID-19 vaccine on the premises there. Modi will visit the plant of the main pharmaceutical Zydus Cadila in Ahmedabad to obtain information on the development of its vaccine, said …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: November 27, 2020 7:10:08 am Half dose followed by a full dose was not the intended regimen. (University of Oxford via AP) An error in the AstraZeneca-University of Oxford vaccine trials, AZD1222, has questioned the way vaccine clinical trials have been …
Read More »
IBS is conducting clinical trials of AstraZeneca-Oxford’s COVID-19 vaccine in India. (Representative) New Delhi: The leading Serum Institute of India for vaccines said Thursday that the COVID-19 vaccine developed by AstraZeneca and the University of Oxford is safe and effective, and that Indian trials are progressing smoothly with strict adherence …
Read More »
Earlier this year, front-line workers such as doctors and nurses were said to be the first to get vaccinated, NDTV reported. When will the vaccine be available to the general public? Speaking at the Hindustan Times Leadership Summit 2020, Poonawalla said: “I never dreamed that at the Serum Institute of …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: November 24, 2020 7:37:08 am The AstraZeneca-Oxford vaccine is called AZ1222; its Indian version, Covishield, is currently in late-stage testing. (Reuters photo) The Swedish-British company AstraZeneca and the University of Oxford information published on Monday on the effectiveness of his vaccine, …
Read More »
Interim Phase 3 analysis of the Oxford / AstraZeneca Covid-19 vaccine candidate showed a 70.4 percent efficacy in preventing the disease, Oxford University announced on Monday. At two different dosing regimens, the vaccine, AZD1222, was 90% and 62% effective. In the most effective dosing regimen, AZD1222 was administered as a …
Read More »
The availability of a vaccine is subject to the results of ongoing trials and licenses. (Figurative) India hopes to start rolling out a COVID-19 vaccine by March 2021, but faces a huge challenge: the cold chain and distribution infrastructure. The nation with the second highest infections in the world plans …
Read More »
The Astra-Oxford vaccine prevented an average of 70% of cases in large trials in the UK and Brazil. (Archive) Highlight Astra and Oxford are taking a different approach than Pfizer and Moderna Astra-Oxford vaccine prevented on average 70% of cases in large trials Scientists will now take a closer look …
Read More »